The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients
Status:
Recruiting
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The (World Health Organization) WHO NOR- (Coronavirus infectious disease) COVID 19 study is a
multi-centre, adaptive, randomized, open clinical trial to evaluate the safety and efficacy
of hydroxychloroquine, remdesivir and standard of care in hospitalized adult patients
diagnosed with COVID-19. This trial will follow the core WHO protocol but has additional
efficacy, safety and explorative endpoints.